Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Precision Medicine in the Adjuvant Setting: a Phase 3 Clinical Trial in Biliary Tract Cancer

NCT07745296 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07745296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07745296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Precision Medicine in the Adjuvant Setting: a Phase 3 Clinical Trial in Biliary Tract Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 2, 2027
Completion date
July 2, 2033
Enrollment
990 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer (btc)